← Back to Search

Other

Inhibition Group for Obesity (STS Trial)

N/A
Waitlist Available
Led By Marta Y Pepino, PhD
Research Sponsored by University of Illinois at Urbana-Champaign
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Be between 18 and 65 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up up to 5 hours after drinking a glucose load
Awards & highlights

STS Trial Summary

This trial will help researchers understand how low-calorie sweeteners may affect metabolism and health.

STS Trial Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~up to 5 hours after drinking a glucose load
This trial's timeline: 3 weeks for screening, Varies for treatment, and up to 5 hours after drinking a glucose load for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
Plasma C-Peptide
Plasma Glucose
Plasma Insulin
+1 more

STS Trial Design

2Treatment groups
Experimental Treatment
Group I: Stimulation GroupExperimental Treatment4 Interventions
Randomly selected habitual and non habitual LCS consumers will be assessed on three different oral glucose tolerance test conditions (i.e. Control - Stimulation, Experimental I- Stimulation, Experimental II -Stimulation). A separate visit will evaluate their sweet taste perception and preferences (Sensory evaluation).
Group II: Inhibition GroupExperimental Treatment4 Interventions
Randomly selected habitual and non habitual LCS consumers will be assessed on three different oral glucose tolerance test conditions (i.e. Control - Inhibition, Experimental I- Inhibition, Experimental II- Inhibition). A separate visit will evaluate their sweet taste perception and preferences (Sensory evaluation).

Find a Location

Who is running the clinical trial?

Washington University School of MedicineOTHER
1,931 Previous Clinical Trials
2,299,629 Total Patients Enrolled
77 Trials studying Obesity
13,737 Patients Enrolled for Obesity
University of Illinois at Urbana-ChampaignLead Sponsor
188 Previous Clinical Trials
37,255 Total Patients Enrolled
22 Trials studying Obesity
2,410 Patients Enrolled for Obesity
Marta Y Pepino, PhDPrincipal InvestigatorUniversity of Illinois at Urbana-Champaign
2 Previous Clinical Trials
138 Total Patients Enrolled
2 Trials studying Obesity
138 Patients Enrolled for Obesity

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

Is this trial seeking new participants at present?

"Per clinicaltrials.gov, this trial has been open to participants since April 24th 2019 and was recently modified on the 26th of April 2021 - it is still actively recruiting individuals for participation."

Answered by AI

Do I meet the qualifications to participate in this research project?

"This research project is looking to recruit 80 individuals within the age range of 21 and 40 years old, who are clinically obese. Furthermore, they must be habitual (>5 diet sodas per week) or non-habitual (≤1 diet soda or 1 packet of LCS per week), not severely insulin resistant (HOMA-IR2 < 2.6), from any race/ethnicity background, with a BMI between 30 and 40 kg/m2."

Answered by AI

To what extent is the population size of this clinical trial?

"Affirmative. Clinicaltrials.gov attests to this clinical trial's ongoing recruitment efforts, which began on April 24th 2019 and were most recently updated on April 26 2021. Right now, 80 patients are needed for the study at one site."

Answered by AI

Does this research investigation admit seniors for participation?

"To enrol in this clinical trial, individuals must be between 21 and 40 years of age. For those under 18 or over 65, 202 and 596 trials respectively are available for them to consider."

Answered by AI
Recent research and studies
~13 spots leftby Apr 2025